These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3717150)

  • 1. Urinary crosslinked fibrin degradation products in glomerular disease.
    Kamitsuji H; Whitworth JA; Dowling JP; Kincaid-Smith P
    Am J Kidney Dis; 1986 Jun; 7(6):452-5. PubMed ID: 3717150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary cross-linked FDP in various renal diseases].
    Inuma H
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary cross-linked fibrin degradation products in glomerular disease with crescents.
    Kamitsuji H; Matsunaga K; Taira K; Nakajima M; Whitworth JA; Kincaid-Smith P
    Clin Nephrol; 1988 Mar; 29(3):124-8. PubMed ID: 3359703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
    Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of urinary fibrin-fibrinogen degradation products (FDP) in various infantile glomerular nephorapathies].
    Tamborine G; Barbieri U; Forese S; Cocconcelli P; Zervos N
    Minerva Pediatr; 1977 Mar; 29(8):525-8. PubMed ID: 865431
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary fibrin/fibrinogen degradation products measured using an anti-fibrinogen antibody predict orthostatic proteinuria.
    Kanai H; Sawanobori E; Kobayashi A; Goto M; Higashida K; Sugita K
    Pediatr Int; 2018 Jul; 60(7):639-644. PubMed ID: 29654610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
    Shibata T; Magari Y; Perparim K; Sumie A; Ishii T; Tomo T; Sato J; Yasumori R; Nasu M
    Nephron; 1995; 69(1):54-8. PubMed ID: 7891798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary crosslinked fibrin degradation products in various renal diseases].
    Kamitsuji H; Whitworth JA; Kincaid-Smith P
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1137-43. PubMed ID: 3807046
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma and urinary levels of adrenomedullin in chronic glomerulonephritis patients with proteinuria.
    Kubo A; Kurioka H; Minamino N; Nishitani Y; Sato H; Nishino T; Iwano M; Shiiki H; Kangawa K; Matsuo H; Dohi K
    Nephron; 1998 Oct; 80(2):227-30. PubMed ID: 9736825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
    Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
    Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary fibrinogen and fibrin fragments in children with renal disease.
    Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
    Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired glomerular lesions in patients with Down syndrome.
    Said SM; Cornell LD; Sethi S; Fidler ME; Al Masri O; Marple J; Nasr SH
    Hum Pathol; 2012 Jan; 43(1):81-8. PubMed ID: 21733549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria and distribution of fibrinogen split products in various forms of glomerulonephritis.
    Reichel W; Wolfrum D; Weber M; Scheler F; Neuhoff V
    Contrib Nephrol; 1975; 1():109-18. PubMed ID: 1235084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
    Miyamura S
    Nihon Jinzo Gakkai Shi; 1978 Jan; 20(1):67-78. PubMed ID: 650992
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of urinary fibrin/fibrinogen degradation products by radioimmunoassay.
    Ekberg M; Hedner U; Larsson I; Nilsson IM; Nosslin B
    Scand J Clin Lab Invest; 1976 Sep; 36(5):453-9. PubMed ID: 790536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
    Blainey JD; Terry JM
    Clin Nephrol; 1979 Mar; 11(3):140-1. PubMed ID: 436342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis.
    Kanai H; Mitsuhashi H; Ono K; Yano S; Naruse T
    Nephron; 1994; 66(4):391-5. PubMed ID: 8015640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.